Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 6
1983 2
1984 3
1990 1
1993 1
1997 5
1998 3
1999 2
2000 2
2001 6
2002 1
2003 2
2004 1
2005 1
2006 2
2007 1
2008 3
2009 1
2010 2
2011 6
2012 3
2013 1
2014 7
2015 12
2016 9
2017 11
2018 13
2019 6
2020 6
2021 13
2022 11
2023 11
2024 5
2025 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
Kwatra SG, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Lynde C, De Bruin-Weller MS, Nahm WK, Sauder M, Gharib R, Barbarot S, Szepietowski JC, Conrad C, Fleischer A, Laquer VT, Misery L, Serra-Baldrich E, Lapeere H, Ahmad F, Jabbar Lopez ZK, Piketty C, Ständer S; OLYMPIA 2 Investigators. Kwatra SG, et al. N Engl J Med. 2023 Oct 26;389(17):1579-1589. doi: 10.1056/NEJMoa2301333. N Engl J Med. 2023. PMID: 37888917 Clinical Trial.
Abrocitinib induction, randomized withdrawal, and retreatment in patients with moderate-to-severe atopic dermatitis: Results from the JAK1 Atopic Dermatitis Efficacy and Safety (JADE) REGIMEN phase 3 trial.
Blauvelt A, Silverberg JI, Lynde CW, Bieber T, Eisman S, Zdybski J, Gubelin W, Simpson EL, Valenzuela F, Criado PR, Lebwohl MG, Feeney C, Khan T, Biswas P, DiBonaventura M, Valdez H, Cameron MC, Rojo R. Blauvelt A, et al. Among authors: lynde cw. J Am Acad Dermatol. 2022 Jan;86(1):104-112. doi: 10.1016/j.jaad.2021.05.075. Epub 2021 Aug 17. J Am Acad Dermatol. 2022. PMID: 34416294 Free article. Clinical Trial.
'Rex noster insanit'.
Henderson Berg MH, Lynde CW, Lynde CB, Kraft JN. Henderson Berg MH, et al. Among authors: lynde cw. J Cutan Med Surg. 2018 Mar/Apr;22(2):246. doi: 10.1177/1203475417745828. J Cutan Med Surg. 2018. PMID: 29587519 No abstract available.
Acitretin revisited.
Lynde CW, Kraft JN, Lynde CB. Lynde CW, et al. Skin Therapy Lett. 2011 Mar;16(3):1-4. Skin Therapy Lett. 2011. PMID: 21611678 Free article.
Acitretin Use in Dermatology.
Guenther LC, Kunynetz R, Lynde CW, Sibbald RG, Toole J, Vender R, Zip C. Guenther LC, et al. Among authors: lynde cw. J Cutan Med Surg. 2017 Nov/Dec;21(3_suppl):2S-12S. doi: 10.1177/1203475417733414. Epub 2017 Sep 27. J Cutan Med Surg. 2017. PMID: 28952335 Review.
Adult-Onset Atopic Dermatitis: Presentations and Progress.
Chan AR, Sandhu VK, Drucker AM, Fleming P, Lynde CW. Chan AR, et al. Among authors: lynde cw. J Cutan Med Surg. 2020 May/Jun;24(3):267-272. doi: 10.1177/1203475420911896. Epub 2020 Apr 2. J Cutan Med Surg. 2020. PMID: 32238071 Review.
Real-World Effectiveness of Risankizumab in Patients with Moderate-to-Severe Psoriasis: Interim Analysis from the VALUE Global Prospective Post-marketing Observational Study at 25 Months.
Thaçi D, Ohtsuki M, Maul JT, Szegedi A, Luna PC, Lynde CW, Soliman AM, Wang H, Kaufmann C, Ashley DG, Madihlaba T, Rubant S, Papp KA. Thaçi D, et al. Among authors: lynde cw. Dermatol Ther (Heidelb). 2025 Feb;15(2):381-394. doi: 10.1007/s13555-025-01342-0. Epub 2025 Feb 4. Dermatol Ther (Heidelb). 2025. PMID: 39904971 Free PMC article.
153 results